Global Pneumococcal Vaccine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
Summary
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
1. To analyze and research the global Pneumococcal Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pneumococcal Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pneumococcal Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Pneumococcal Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pneumococcal Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pneumococcal Vaccine industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pneumococcal Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.
23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
According to APO Research, The global Pneumococcal Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
North American market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pneumococcal Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur and CDIBP, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Pneumococcal Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.
Pneumococcal Vaccine segment by Company
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global Pneumococcal Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Pneumococcal Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Pneumococcal Vaccine significant trends, drivers, influence factors in global and regions.
6. To analyze Pneumococcal Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pneumococcal Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pneumococcal Vaccine industry.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Pneumococcal Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Pneumococcal Vaccine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pneumococcal Vaccine Sales Value (2019-2030)
1.2.2 Global Pneumococcal Vaccine Sales Volume (2019-2030)
1.2.3 Global Pneumococcal Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 PNEUMOCOCCAL VACCINE MARKET BY COMPANY
3.1 Global Pneumococcal Vaccine Company Revenue Ranking in 2023
3.2 Global Pneumococcal Vaccine Revenue by Company (2019-2024)
3.3 Global Pneumococcal Vaccine Sales Volume by Company (2019-2024)
3.4 Global Pneumococcal Vaccine Average Price by Company (2019-2024)
3.5 Global Pneumococcal Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Pneumococcal Vaccine Company Manufacturing Base & Headquarters
3.7 Global Pneumococcal Vaccine Company, Product Type & Application
3.8 Global Pneumococcal Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINE MARKET BY TYPE
4.1 Pneumococcal Vaccine Type Introduction
4.1.1 PPSV
4.1.2 PCV 7/13
4.1.3 PCV
4.2 Global Pneumococcal Vaccine Sales Volume by Type
4.2.1 Global Pneumococcal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pneumococcal Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccine Sales Value by Type
4.3.1 Global Pneumococcal Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pneumococcal Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Pneumococcal Vaccine Sales Value Share by Type (2019-2030)
5 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
5.1 Pneumococcal Vaccine Application Introduction
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Sales Volume by Application
5.2.1 Global Pneumococcal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Pneumococcal Vaccine Sales Value by Application
5.3.1 Global Pneumococcal Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pneumococcal Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Pneumococcal Vaccine Sales Value Share by Application (2019-2030)
6 PNEUMOCOCCAL VACCINE MARKET BY REGION
6.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pneumococcal Vaccine Sales by Region (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
6.2.2 Global Pneumococcal Vaccine Sales by Region (2025-2030)
6.3 Global Pneumococcal Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Pneumococcal Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Pneumococcal Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Pneumococcal Vaccine Sales Value by Region (2025-2030)
6.5 Global Pneumococcal Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Pneumococcal Vaccine Sales Value (2019-2030)
6.6.2 North America Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Pneumococcal Vaccine Sales Value (2019-2030)
6.7.2 Europe Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pneumococcal Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Pneumococcal Vaccine Sales Value (2019-2030)
6.9.2 Latin America Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pneumococcal Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
7 PNEUMOCOCCAL VACCINE MARKET BY COUNTRY
7.1 Global Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Pneumococcal Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Pneumococcal Vaccine Sales by Country (2019-2030)
7.3.1 Global Pneumococcal Vaccine Sales by Country (2019-2024)
7.3.2 Global Pneumococcal Vaccine Sales by Country (2025-2030)
7.4 Global Pneumococcal Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Pneumococcal Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Pneumococcal Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Pfizer
8.1.1 Pfizer Comapny Information
8.1.2 Pfizer Business Overview
8.1.3 Pfizer Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
8.1.5 Pfizer Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Pneumococcal Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 MSD
8.3.1 MSD Comapny Information
8.3.2 MSD Business Overview
8.3.3 MSD Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 MSD Pneumococcal Vaccine Product Portfolio
8.3.5 MSD Recent Developments
8.4 Sanofipasteur
8.4.1 Sanofipasteur Comapny Information
8.4.2 Sanofipasteur Business Overview
8.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
8.4.5 Sanofipasteur Recent Developments
8.5 CDIBP
8.5.1 CDIBP Comapny Information
8.5.2 CDIBP Business Overview
8.5.3 CDIBP Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
8.5.5 CDIBP Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pneumococcal Vaccine Value Chain Analysis
9.1.1 Pneumococcal Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pneumococcal Vaccine Sales Mode & Process
9.2 Pneumococcal Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pneumococcal Vaccine Distributors
9.2.3 Pneumococcal Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pneumococcal Vaccine Sales Value (2019-2030)
1.2.2 Global Pneumococcal Vaccine Sales Volume (2019-2030)
1.2.3 Global Pneumococcal Vaccine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 PNEUMOCOCCAL VACCINE MARKET DYNAMICS
2.1 Pneumococcal Vaccine Industry Trends
2.2 Pneumococcal Vaccine Industry Drivers
2.3 Pneumococcal Vaccine Industry Opportunities and Challenges
2.4 Pneumococcal Vaccine Industry Restraints
3 PNEUMOCOCCAL VACCINE MARKET BY COMPANY
3.1 Global Pneumococcal Vaccine Company Revenue Ranking in 2023
3.2 Global Pneumococcal Vaccine Revenue by Company (2019-2024)
3.3 Global Pneumococcal Vaccine Sales Volume by Company (2019-2024)
3.4 Global Pneumococcal Vaccine Average Price by Company (2019-2024)
3.5 Global Pneumococcal Vaccine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Pneumococcal Vaccine Company Manufacturing Base & Headquarters
3.7 Global Pneumococcal Vaccine Company, Product Type & Application
3.8 Global Pneumococcal Vaccine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Pneumococcal Vaccine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Pneumococcal Vaccine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL VACCINE MARKET BY TYPE
4.1 Pneumococcal Vaccine Type Introduction
4.1.1 PPSV
4.1.2 PCV 7/13
4.1.3 PCV
4.2 Global Pneumococcal Vaccine Sales Volume by Type
4.2.1 Global Pneumococcal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Pneumococcal Vaccine Sales Volume by Type (2019-2030)
4.2.3 Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2030)
4.3 Global Pneumococcal Vaccine Sales Value by Type
4.3.1 Global Pneumococcal Vaccine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Pneumococcal Vaccine Sales Value by Type (2019-2030)
4.3.3 Global Pneumococcal Vaccine Sales Value Share by Type (2019-2030)
5 PNEUMOCOCCAL VACCINE MARKET BY APPLICATION
5.1 Pneumococcal Vaccine Application Introduction
5.1.1 Child
5.1.2 Adult
5.2 Global Pneumococcal Vaccine Sales Volume by Application
5.2.1 Global Pneumococcal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Pneumococcal Vaccine Sales Volume by Application (2019-2030)
5.2.3 Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2030)
5.3 Global Pneumococcal Vaccine Sales Value by Application
5.3.1 Global Pneumococcal Vaccine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Pneumococcal Vaccine Sales Value by Application (2019-2030)
5.3.3 Global Pneumococcal Vaccine Sales Value Share by Application (2019-2030)
6 PNEUMOCOCCAL VACCINE MARKET BY REGION
6.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Pneumococcal Vaccine Sales by Region (2019-2030)
6.2.1 Global Pneumococcal Vaccine Sales by Region: 2019-2024
6.2.2 Global Pneumococcal Vaccine Sales by Region (2025-2030)
6.3 Global Pneumococcal Vaccine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Pneumococcal Vaccine Sales Value by Region (2019-2030)
6.4.1 Global Pneumococcal Vaccine Sales Value by Region: 2019-2024
6.4.2 Global Pneumococcal Vaccine Sales Value by Region (2025-2030)
6.5 Global Pneumococcal Vaccine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Pneumococcal Vaccine Sales Value (2019-2030)
6.6.2 North America Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Pneumococcal Vaccine Sales Value (2019-2030)
6.7.2 Europe Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Pneumococcal Vaccine Sales Value (2019-2030)
6.8.2 Asia-Pacific Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Pneumococcal Vaccine Sales Value (2019-2030)
6.9.2 Latin America Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Pneumococcal Vaccine Sales Value (2019-2030)
6.10.2 Middle East & Africa Pneumococcal Vaccine Sales Value Share by Country, 2023 VS 2030
7 PNEUMOCOCCAL VACCINE MARKET BY COUNTRY
7.1 Global Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Pneumococcal Vaccine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Pneumococcal Vaccine Sales by Country (2019-2030)
7.3.1 Global Pneumococcal Vaccine Sales by Country (2019-2024)
7.3.2 Global Pneumococcal Vaccine Sales by Country (2025-2030)
7.4 Global Pneumococcal Vaccine Sales Value by Country (2019-2030)
7.4.1 Global Pneumococcal Vaccine Sales Value by Country (2019-2024)
7.4.2 Global Pneumococcal Vaccine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.5.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.6.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.7.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.8.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.9.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.10.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.11.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.12.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.13.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.14.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.15.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.16.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.17.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.18.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.19.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.20.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.21.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.22.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Pneumococcal Vaccine Sales Value Growth Rate (2019-2030)
7.23.2 Global Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030
8 COMPANY PROFILES
8.1 Pfizer
8.1.1 Pfizer Comapny Information
8.1.2 Pfizer Business Overview
8.1.3 Pfizer Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.1.4 Pfizer Pneumococcal Vaccine Product Portfolio
8.1.5 Pfizer Recent Developments
8.2 GSK
8.2.1 GSK Comapny Information
8.2.2 GSK Business Overview
8.2.3 GSK Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.2.4 GSK Pneumococcal Vaccine Product Portfolio
8.2.5 GSK Recent Developments
8.3 MSD
8.3.1 MSD Comapny Information
8.3.2 MSD Business Overview
8.3.3 MSD Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.3.4 MSD Pneumococcal Vaccine Product Portfolio
8.3.5 MSD Recent Developments
8.4 Sanofipasteur
8.4.1 Sanofipasteur Comapny Information
8.4.2 Sanofipasteur Business Overview
8.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.4.4 Sanofipasteur Pneumococcal Vaccine Product Portfolio
8.4.5 Sanofipasteur Recent Developments
8.5 CDIBP
8.5.1 CDIBP Comapny Information
8.5.2 CDIBP Business Overview
8.5.3 CDIBP Pneumococcal Vaccine Sales, Value and Gross Margin (2019-2024)
8.5.4 CDIBP Pneumococcal Vaccine Product Portfolio
8.5.5 CDIBP Recent Developments
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS
9.1 Pneumococcal Vaccine Value Chain Analysis
9.1.1 Pneumococcal Vaccine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pneumococcal Vaccine Sales Mode & Process
9.2 Pneumococcal Vaccine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pneumococcal Vaccine Distributors
9.2.3 Pneumococcal Vaccine Customers
10 CONCLUDING INSIGHTS
11 APPENDIX
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
LIST OF TABLES
Table 1. Pneumococcal Vaccine Industry Trends
Table 2. Pneumococcal Vaccine Industry Drivers
Table 3. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 4. Pneumococcal Vaccine Industry Restraints
Table 5. Global Pneumococcal Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pneumococcal Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales Volume by Company (K Doses) & (2019-2024)
Table 8. Global Pneumococcal Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Pneumococcal Vaccine Average Price (USD/Dose) of Company (2019-2024)
Table 10. Global Pneumococcal Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Pneumococcal Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Pneumococcal Vaccine Company, Product Type & Application
Table 13. Global Pneumococcal Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of PPSV 23
Table 18. Major Companies of PCV 7/13
Table 19. Major Companies of PCV 10
Table 20. Global Pneumococcal Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (K Doses)
Table 21. Global Pneumococcal Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 22. Global Pneumococcal Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 23. Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2024)
Table 24. Global Pneumococcal Vaccine Sales Volume Share by Type (2025-2030)
Table 25. Global Pneumococcal Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Pneumococcal Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Pneumococcal Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Pneumococcal Vaccine Sales Value Share by Type (2019-2024)
Table 29. Global Pneumococcal Vaccine Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Child
Table 31. Major Companies of Adult
Table 32. Global Pneumococcal Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (K Doses)
Table 33. Global Pneumococcal Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 34. Global Pneumococcal Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 35. Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global Pneumococcal Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global Pneumococcal Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Pneumococcal Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Pneumococcal Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Pneumococcal Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global Pneumococcal Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 43. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 44. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 46. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global Pneumococcal Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Pneumococcal Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global Pneumococcal Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Pneumococcal Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global Pneumococcal Vaccine Market Average Price (USD/Dose) by Region (2019-2024)
Table 53. Global Pneumococcal Vaccine Market Average Price (USD/Dose) by Region (2025-2030)
Table 54. Global Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 55. Global Pneumococcal Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 57. Global Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 59. Global Pneumococcal Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global Pneumococcal Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Pneumococcal Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global Pneumococcal Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Pneumococcal Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Pfizer Company Information
Table 65. Pfizer Business Overview
Table 66. Pfizer Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 67. Pfizer Pneumococcal Vaccine Product Portfolio
Table 68. Pfizer Recent Development
Table 69. GSK Company Information
Table 70. GSK Business Overview
Table 71. GSK Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 72. GSK Pneumococcal Vaccine Product Portfolio
Table 73. GSK Recent Development
Table 74. MSD Company Information
Table 75. MSD Business Overview
Table 76. MSD Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 77. MSD Pneumococcal Vaccine Product Portfolio
Table 78. MSD Recent Development
Table 79. Sanofipasteur Company Information
Table 80. Sanofipasteur Business Overview
Table 81. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 83. Sanofipasteur Recent Development
Table 84. CDIBP Company Information
Table 85. CDIBP Business Overview
Table 86. CDIBP Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. CDIBP Pneumococcal Vaccine Product Portfolio
Table 88. CDIBP Recent Development
Table 89. Key Raw Materials
Table 90. Raw Materials Key Suppliers
Table 91. Pneumococcal Vaccine Distributors List
Table 92. Pneumococcal Vaccine Customers List
Table 93. Research Programs/Design for This Report
Table 94. Authors List of This Report
Table 95. Secondary Sources
Table 96. Primary Sources
Table 1. Pneumococcal Vaccine Industry Trends
Table 2. Pneumococcal Vaccine Industry Drivers
Table 3. Pneumococcal Vaccine Industry Opportunities and Challenges
Table 4. Pneumococcal Vaccine Industry Restraints
Table 5. Global Pneumococcal Vaccine Revenue by Company (US$ Million) & (2019-2024)
Table 6. Global Pneumococcal Vaccine Revenue Share by Company (2019-2024)
Table 7. Global Pneumococcal Vaccine Sales Volume by Company (K Doses) & (2019-2024)
Table 8. Global Pneumococcal Vaccine Sales Volume Share by Company (2019-2024)
Table 9. Global Pneumococcal Vaccine Average Price (USD/Dose) of Company (2019-2024)
Table 10. Global Pneumococcal Vaccine Company Ranking, 2022 VS 2023 VS 2024 & (US$ Million)
Table 11. Global Pneumococcal Vaccine Key Company Manufacturing Base & Headquarters
Table 12. Global Pneumococcal Vaccine Company, Product Type & Application
Table 13. Global Pneumococcal Vaccine Company Commercialization Time
Table 14. Global Company Market Concentration Ratio (CR5 and HHI)
Table 15. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2023)
Table 16. Mergers & Acquisitions, Expansion
Table 17. Major Companies of PPSV 23
Table 18. Major Companies of PCV 7/13
Table 19. Major Companies of PCV 10
Table 20. Global Pneumococcal Vaccine Sales Volume by Type 2019 VS 2023 VS 2030 (K Doses)
Table 21. Global Pneumococcal Vaccine Sales Volume by Type (2019-2024) & (K Doses)
Table 22. Global Pneumococcal Vaccine Sales Volume by Type (2025-2030) & (K Doses)
Table 23. Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2024)
Table 24. Global Pneumococcal Vaccine Sales Volume Share by Type (2025-2030)
Table 25. Global Pneumococcal Vaccine Sales Value by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 26. Global Pneumococcal Vaccine Sales Value by Type (2019-2024) & (US$ Million)
Table 27. Global Pneumococcal Vaccine Sales Value by Type (2025-2030) & (US$ Million)
Table 28. Global Pneumococcal Vaccine Sales Value Share by Type (2019-2024)
Table 29. Global Pneumococcal Vaccine Sales Value Share by Type (2025-2030)
Table 30. Major Companies of Child
Table 31. Major Companies of Adult
Table 32. Global Pneumococcal Vaccine Sales Volume by Application 2019 VS 2023 VS 2030 (K Doses)
Table 33. Global Pneumococcal Vaccine Sales Volume by Application (2019-2024) & (K Doses)
Table 34. Global Pneumococcal Vaccine Sales Volume by Application (2025-2030) & (K Doses)
Table 35. Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2024)
Table 36. Global Pneumococcal Vaccine Sales Volume Share by Application (2025-2030)
Table 37. Global Pneumococcal Vaccine Sales Value by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 38. Global Pneumococcal Vaccine Sales Value by Application (2019-2024) & (US$ Million)
Table 39. Global Pneumococcal Vaccine Sales Value by Application (2025-2030) & (US$ Million)
Table 40. Global Pneumococcal Vaccine Sales Value Share by Application (2019-2024)
Table 41. Global Pneumococcal Vaccine Sales Value Share by Application (2025-2030)
Table 42. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Table 43. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)
Table 44. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)
Table 45. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)
Table 46. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)
Table 47. Global Pneumococcal Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 48. Global Pneumococcal Vaccine Sales Value by Region (2019-2024) & (US$ Million)
Table 49. Global Pneumococcal Vaccine Sales Value Share by Region (2019-2024)
Table 50. Global Pneumococcal Vaccine Sales Value by Region (2025-2030) & (US$ Million)
Table 51. Global Pneumococcal Vaccine Sales Value Share by Region (2025-2030)
Table 52. Global Pneumococcal Vaccine Market Average Price (USD/Dose) by Region (2019-2024)
Table 53. Global Pneumococcal Vaccine Market Average Price (USD/Dose) by Region (2025-2030)
Table 54. Global Pneumococcal Vaccine Sales by Country: 2019 VS 2023 VS 2030 (K Doses)
Table 55. Global Pneumococcal Vaccine Sales Value by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. Global Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)
Table 57. Global Pneumococcal Vaccine Sales Market Share by Country (2019-2024)
Table 58. Global Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)
Table 59. Global Pneumococcal Vaccine Sales Market Share by Country (2025-2030)
Table 60. Global Pneumococcal Vaccine Sales Value by Country (2019-2024) & (US$ Million)
Table 61. Global Pneumococcal Vaccine Sales Value Market Share by Country (2019-2024)
Table 62. Global Pneumococcal Vaccine Sales Value by Country (2025-2030) & (US$ Million)
Table 63. Global Pneumococcal Vaccine Sales Value Market Share by Country (2025-2030)
Table 64. Pfizer Company Information
Table 65. Pfizer Business Overview
Table 66. Pfizer Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 67. Pfizer Pneumococcal Vaccine Product Portfolio
Table 68. Pfizer Recent Development
Table 69. GSK Company Information
Table 70. GSK Business Overview
Table 71. GSK Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 72. GSK Pneumococcal Vaccine Product Portfolio
Table 73. GSK Recent Development
Table 74. MSD Company Information
Table 75. MSD Business Overview
Table 76. MSD Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 77. MSD Pneumococcal Vaccine Product Portfolio
Table 78. MSD Recent Development
Table 79. Sanofipasteur Company Information
Table 80. Sanofipasteur Business Overview
Table 81. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Sanofipasteur Pneumococcal Vaccine Product Portfolio
Table 83. Sanofipasteur Recent Development
Table 84. CDIBP Company Information
Table 85. CDIBP Business Overview
Table 86. CDIBP Pneumococcal Vaccine Sales (K Doses), Value (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 87. CDIBP Pneumococcal Vaccine Product Portfolio
Table 88. CDIBP Recent Development
Table 89. Key Raw Materials
Table 90. Raw Materials Key Suppliers
Table 91. Pneumococcal Vaccine Distributors List
Table 92. Pneumococcal Vaccine Customers List
Table 93. Research Programs/Design for This Report
Table 94. Authors List of This Report
Table 95. Secondary Sources
Table 96. Primary Sources
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Global Pneumococcal Vaccine Sales Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Pneumococcal Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. PPSV 23 Picture
Figure 10. PCV 7/13 Picture
Figure 11. PCV 10 Picture
Figure 12. Global Pneumococcal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 13. Global Pneumococcal Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 14. Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2030)
Figure 15. Global Pneumococcal Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Pneumococcal Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Pneumococcal Vaccine Sales Value Share by Type (2019-2030)
Figure 18. Child Picture
Figure 19. Adult Picture
Figure 20. Global Pneumococcal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 21. Global Pneumococcal Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global Pneumococcal Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Pneumococcal Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Pneumococcal Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Figure 27. Global Pneumococcal Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Pneumococcal Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Pneumococcal Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi Arabia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 94. UAE Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 95. UAE Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 96. UAE Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 97. Pneumococcal Vaccine Value Chain
Figure 98. Manufacturing Cost Structure
Figure 99. Pneumococcal Vaccine Sales Mode & Process
Figure 100. Direct Comparison with Distribution Share
Figure 101. Distributors Profiles
Figure 102. Years Considered
Figure 103. Research Process
Figure 104. Key Executives Interviewed
Figure 1. Pneumococcal Vaccine Product Picture
Figure 2. Global Pneumococcal Vaccine Sales Value (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Pneumococcal Vaccine Sales (2019-2030) & (K Doses)
Figure 5. Global Pneumococcal Vaccine Sales Average Price (USD/Dose) & (2019-2030)
Figure 6. Global Pneumococcal Vaccine Company Revenue Ranking in 2023 (US$ Million)
Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2023 (US$ Million)
Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 9. PPSV 23 Picture
Figure 10. PCV 7/13 Picture
Figure 11. PCV 10 Picture
Figure 12. Global Pneumococcal Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Doses)
Figure 13. Global Pneumococcal Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 14. Global Pneumococcal Vaccine Sales Volume Share by Type (2019-2030)
Figure 15. Global Pneumococcal Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Pneumococcal Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 17. Global Pneumococcal Vaccine Sales Value Share by Type (2019-2030)
Figure 18. Child Picture
Figure 19. Adult Picture
Figure 20. Global Pneumococcal Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Doses)
Figure 21. Global Pneumococcal Vaccine Sales Volume Share 2019 VS 2023 VS 2030
Figure 22. Global Pneumococcal Vaccine Sales Volume Share by Application (2019-2030)
Figure 23. Global Pneumococcal Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Pneumococcal Vaccine Sales Value Share 2019 VS 2023 VS 2030
Figure 25. Global Pneumococcal Vaccine Sales Value Share by Application (2019-2030)
Figure 26. Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030 (K Doses)
Figure 27. Global Pneumococcal Vaccine Sales Market Share by Region: 2019 VS 2023 VS 2030
Figure 28. Global Pneumococcal Vaccine Sales Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 29. Global Pneumococcal Vaccine Sales Value Share by Region: 2019 VS 2023 VS 2030
Figure 30. North America Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 31. North America Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 32. Europe Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 33. Europe Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 34. Asia-Pacific Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 36. Latin America Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 37. Latin America Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 38. Middle East & Africa Pneumococcal Vaccine Sales Value (2019-2030) & (US$ Million)
Figure 39. Middle East & Africa Pneumococcal Vaccine Sales Value Share by Country (%), 2023 VS 2030
Figure 40. USA Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 41. USA Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 42. USA Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 43. Canada Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 44. Canada Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 45. Canada Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 46. Germany Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 47. Germany Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 48. Germany Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 49. France Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 50. France Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 51. France Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 52. U.K. Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.K. Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 54. U.K. Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 55. Italy Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 56. Italy Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 57. Italy Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 58. Netherlands Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 59. Netherlands Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 60. Netherlands Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 61. Nordic Countries Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Nordic Countries Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 63. Nordic Countries Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 64. China Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 65. China Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 66. China Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 67. Japan Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 68. Japan Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 69. Japan Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 70. South Korea Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 71. South Korea Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 72. South Korea Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 73. Southeast Asia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 74. Southeast Asia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 75. Southeast Asia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 76. India Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. India Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 78. India Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 79. Australia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Australia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 81. Australia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 82. Mexico Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 83. Mexico Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 84. Mexico Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 85. Brazil Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 86. Brazil Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 87. Brazil Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 88. Turkey Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 89. Turkey Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 90. Turkey Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 91. Saudi Arabia Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 92. Saudi Arabia Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 93. Saudi Arabia Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 94. UAE Pneumococcal Vaccine Sales Value Growth Rate (2019-2030) & (US$ Million)
Figure 95. UAE Pneumococcal Vaccine Sales Value Share by Type, 2023 VS 2030 & (%)
Figure 96. UAE Pneumococcal Vaccine Sales Value Share by Application, 2023 VS 2030 & (%)
Figure 97. Pneumococcal Vaccine Value Chain
Figure 98. Manufacturing Cost Structure
Figure 99. Pneumococcal Vaccine Sales Mode & Process
Figure 100. Direct Comparison with Distribution Share
Figure 101. Distributors Profiles
Figure 102. Years Considered
Figure 103. Research Process
Figure 104. Key Executives Interviewed
